Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

Diana Hernández, Daniel J. Feaster, Lauren Gooden, Antoine Douaihy, Raul Mandler, Sarah J. Erickson, Tiffany Kyle, Louise Haynes, Robert Schwartz, Moupali Das, Lisa Metsch

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Substance users are at increased risk for HIV and HCV infection. Still, many substance use treatment programs (SUTP) fail to offer HIV/HCV testing. The present secondary analysis of screening data from a multi-site randomized trial of rapid HIV testing examines self-reported HIV/HCV testing patterns and serostatus of 2473 SUTP patients in 12 community-based sites that had not previously offered on-site testing. Results indicate that most respondents screened for the randomized trial tested more than a year prior to intake for HIV (52 %) and HCV (38 %). Prevalence rates were 3.6 and 30 % for HIV and HCV, respectively. The majority of participants that were HIV (52.2 %) and HCV-positive (40.5 %) reported having been diagnosed within the last 1–5 years. Multivariable logistic regression showed that members of high-risk groups were more likely to have tested. Bundled HIV/HCV testing and linkage to care issues are recommended for expanding testing in community-based SUTP settings.

Original languageEnglish (US)
Pages (from-to)204-214
Number of pages11
JournalAIDS and Behavior
Issue number1
StatePublished - Jan 1 2016


  • Community based substance abuse treatment programs
  • HIV/HCV sceening and serostatus
  • HIV/HCV testing and linkage to care
  • Substance abuse treatment patients

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients'. Together they form a unique fingerprint.

Cite this